Page last updated: 2024-11-06

sergolexole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sergolexole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID60262
CHEMBL ID3991393
SCHEMBL ID1812346
SCHEMBL ID22462310
MeSH IDM0154056

Synonyms (15)

Synonym
gtpl211
PDSP1_000757
PDSP2_000745
sergolexole
108674-86-8
j6tga89cop ,
sergolexole [inn]
unii-j6tga89cop
trans-4-methoxycyclohexyl 1-isopropyl-6-methylergoline-8.beta.-carboxylate
SCHEMBL1812346
DTXSID10148700
CHEMBL3991393
Q27088783
SCHEMBL22462310
(4-methoxycyclohexyl) (6ar,9r,10ar)-7-methyl-4-propan-2-yl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-9-carboxylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1259419Human 5-HT2A receptor (5-Hydroxytryptamine receptors)1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID624222Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT2A1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID624223Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
AID1346919Rat 5-HT2A receptor (5-Hydroxytryptamine receptors)1994Molecular pharmacology, Feb, Volume: 45, Issue:2
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (23.08)18.7374
1990's8 (61.54)18.2507
2000's2 (15.38)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.81 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]